Brighthouse Financial (BHF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Apr, 2026Executive summary
Entered into a Merger Agreement in November 2025 for acquisition by an affiliate of Aquarian Capital LLC at $70.00 per share, with closing expected in 2026, subject to regulatory approvals.
2025 saw record annuity and life insurance sales, robust liquidity, and a combined risk-based capital ratio of 456%, above the target range.
Strategic initiatives included simplifying hedging strategies and executing a reinsurance transaction to improve capital efficiency.
Corporate expenses were $880 million, including $31.6 million related to the pending acquisition; excluding these, expenses were better than plan.
Voting matters and shareholder proposals
Stockholders will vote on: (1) election of nine directors for one-year terms, (2) ratification of Deloitte & Touche LLP as independent auditor for 2026, and (3) advisory approval of executive compensation (Say-on-Pay).
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine directors, eight of whom are independent; diverse in skills, experience, and backgrounds.
Annual director elections, majority voting standard, no poison pill, and one share/one vote structure.
Board committees (Audit, Compensation and Human Capital, Finance and Risk, Investment, Nominating and Corporate Governance) are chaired by independent directors.
Regular board and committee self-assessments, director stock ownership guidelines, and mandatory retirement age of 72.
Latest events from Brighthouse Financial
- Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.BHF
Proxy filing14 Apr 2026 - Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 202523 Feb 2026 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 202415 Jan 2026 - Shareholders to vote on $70/share cash merger with Aquarian Holdings; board recommends approval.BHF
Proxy Filing7 Jan 2026 - Q4 2024 net income was $646M, with record annuity and life sales and strong capital metrics.BHF
Q4 202426 Dec 2025 - Shareholders to vote on $70.00 per share cash merger, with board unanimous in recommending approval.BHF
Proxy Filing23 Dec 2025